Roundhill GLP-1 & Weight Loss ETF Rating $27.13 -0.56 (-2.02%) As of 06/13/2025 03:13 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.66Holdings in OZEM have an aggregate rating of Moderate Buy based on 191 analyst ratings issued in the past year covering 14 companies (68.9% of the portfolio).OZEM Aggregate Price Target$27.13High Prediction$27.13Average Prediction$27.13Low Prediction$27.13Holdings in OZEM have an aggregate price target of $27.13 and a range of $27.13 to $27.13 covering 14 companies (68.9% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy5 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 14 OZEM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings20.89%NVONovo Nordisk A/S$79.90-1.4%4.6226 of 5 stars2.27$112.00 40.2%11Trending NewsAnalyst Upgrade13.41%LLYEli Lilly and Company$818.56+0.8%4.8026 of 5 stars2.76$1,011.37 23.6%21Trending NewsAnalyst Revision3.99%VKTXViking Therapeutics$26.08-8.7%4.397 of 5 stars3.00$87.15 234.2%14News CoverageOptions VolumeAnalyst RevisionGap Down3.71%MTSRMetsera$29.38-15.0%N/A3.00$50.00 70.2%4News CoverageAnalyst ForecastAnalyst RevisionGap Down3.57%ALTAltimmune$6.92-3.2%2.3872 of 5 stars3.00$20.20 191.9%7Analyst DowngradeGap Down3.50%GPCRStructure Therapeutics$21.68-2.4%2.4273 of 5 stars3.00$76.50 252.9%7News CoverageAnalyst RevisionGap Down3.41%PFEPfizer$24.51-1.3%4.9747 of 5 stars2.53$29.17 19.0%15Trending NewsAnalyst Revision3.33%AZNAstraZeneca$74.42-0.8%2.859 of 5 stars3.13$85.00 14.2%8Positive NewsAnalyst Revision3.24%AMGNAmgen$295.22-0.7%4.4628 of 5 stars2.38$309.22 4.7%24Positive NewsAnalyst Revision2.94%TERNTerns Pharmaceuticals$3.88-1.3%4.1215 of 5 stars2.60$15.63 302.7%5Positive News1.94%REGNRegeneron Pharmaceuticals$529.24+1.4%4.8807 of 5 stars2.85$836.48 58.1%26Positive NewsAnalyst Revision1.86%SRRKScholar Rock$32.45-2.6%4.3825 of 5 stars3.14$42.67 31.5%7Positive NewsGap Down1.82%GILDGilead Sciences$109.98-1.8%4.8503 of 5 stars2.78$110.55 0.5%27Trending NewsOptions VolumeAnalyst Revision1.30%BHVNBiohaven$15.43-1.1%2.987 of 5 stars3.07$59.46 285.5%15Short Interest ↑Analyst Revision This page (NASDAQ:OZEM) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
